Article
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition.
Nature communications - 21 Sept 2022
Motozono Chihiro, Toyoda Mako, Tan Toong Seng, Hamana Hiroshi, Goto Yoshihiko, Aritsu Yoshiki, Miyashita Yusuke, Oshiumi Hiroyuki, Nakamura Kimitoshi, Okada Seiji, Udaka Keiko, Kitamatsu Mizuki, Kishi Hiroyuki, Ueno Takamasa
Abstract excerpt
Although the Omicron variant of the SARS-CoV-2 virus shows resistance to neutralizing antibody, it retains susceptibility to the cellular immune response. Here we characterize vaccine-induced T cells specific for various SARS-CoV-2 variants and identified HLA-A*24:02-restricted CD8+ T cells that strongly suppress Omicron BA.1 replication in vitro. Mutagenesis analyses revealed that a G446S mutation, located just...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
